Skip to content
CEpartner4U
  • Welcome
  • About us
    • Team
    • Jobs
  • Services
    • AR/EC Rep
    • Regulatory affairs
    • Quality system
    • CE/QMS Entry Packages©
    • Clinical evaluation
    • Training
  • UKCApartner4U
  • Information
    • F.A.Q. AR/EC Rep
    • Links
  • Library
  • News
  • Network
  • Contact

About:m.vandervoort

Posts by m.vandervoort :

  • All documents related to the MDR and IVDR amending Regulations, 26 July 2024 in Uncategorized
  • Manufacturer’s Declaration in relation to Regulation (EU) 2024/1860, 18 July 2024 in Uncategorized
  • MDCG 2021-5 Guidance on standardisation for medical devices – Rev.1 published, 2 July 2024 in Uncategorized
  • MDCG 2024-10 Clinical evaluation of orphan medical devices published, 25 June 2024 in Uncategorized
  • MDCG 2022-13 Designation, re-assessment and notification of conformity assessment bodies and notified bodies – Revision 1, 17 June 2024 in Uncategorized
  • MDCG issues 1 template and 5 guidances on device specific vigilance, 11 June 2024 in Uncategorized
  • MDCG revised guidance 2022-4, 27 May 2024 in Uncategorized
  • MDCG 2024-5 Published on Guidance on the Investigator’s Brochure (MDR), 17 April 2024 in Uncategorized
  • MDCG 2022-9 Rev.1 Summary of safety and performance Template published, 15 April 2024 in Uncategorized
  • MDCG 2024-4 published on Safety reporting in performance studies of in vitro diagnostic medical devices under the IVDR, 15 April 2024 in Uncategorized
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 12
  • »

Stay informed

Please check your inbox or spam box to confirm

Copyright 2026 CEpartner4U | Esdoornlaan 13 | 3951 DB Maarn | The Netherlands | +31.6.516.536.26 | office@cepartner4u.com
  • enEnglish